Coeliac disease detection with an IgA/IgG-deamidated gliadin peptide based point of care test in community pharmacies

Background Coeliac disease affects 1% of the population, but 75% remain undiagnosed. Objective To conduct a case finding feasibility and efficacy study for the detection of coeliac disease in community pharmacies. Setting Six community pharmacies across Sheffield, UK. Method A prospective study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Michelle S., Sanders, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509084/
https://www.ncbi.nlm.nih.gov/pubmed/30778740
http://dx.doi.org/10.1007/s11096-019-00793-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509084/
https://www.ncbi.nlm.nih.gov/pubmed/30778740
http://dx.doi.org/10.1007/s11096-019-00793-8

Ejemplares similares